NCT04774107 - The Pharmacokinetics of P1101 + Ribavirin in Interferon Treatment-Naïve Subjects With Chronic Hepatitis C Virus (HCV) Genotype 2 Infection | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 26, 2020

Primary Completion Date

July 18, 2022

Study Completion Date

July 18, 2022

Conditions

Hepatitis C, Chronic

Interventions

DRUG

P1101 + Ribavirin

P1101 400 µg SC

Trial Locations (5)

Chang Gung Memorial Hospital, Chiayi Branch, Chiayi City

Chia-Yi Christian Hospital, Chiayi City

St. Martin De Porres Hospital, Chiayi City

Kaohsiung Medical University Hospital, Kaohsiung City

Chi Mei Medical Center, Tainan City